File Download

There are no files associated with this item.

Supplementary

Article: Initiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone

TitleInitiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone
Authors
Wong, CKHLau, TKKAU, CHXIONG, XChung, HSLeung, BYCLau, EHYCowling, BJ
Issue Date2022
Citation
Frontiers in Pharmacology, 2022 How to Cite?
Persistent Identifierhttp://hdl.handle.net/10722/313223

 

DC FieldValueLanguage
dc.contributor.authorWong, CKH-
dc.contributor.authorLau, TKK-
dc.contributor.authorAU, CH-
dc.contributor.authorXIONG, X-
dc.contributor.authorChung, HS-
dc.contributor.authorLeung, BYC-
dc.contributor.authorLau, EHY-
dc.contributor.authorCowling, BJ-
dc.date.accessioned2022-06-06T05:47:52Z-
dc.date.available2022-06-06T05:47:52Z-
dc.date.issued2022-
dc.identifier.citationFrontiers in Pharmacology, 2022-
dc.identifier.urihttp://hdl.handle.net/10722/313223-
dc.languageeng-
dc.relation.ispartofFrontiers in Pharmacology-
dc.titleInitiation of Tocilizumab or Baricitinib Were Associated With Comparable Clinical Outcomes Among Patients Hospitalized With COVID-19 and Treated With Dexamethasone-
dc.typeArticle-
dc.identifier.emailWong, CKH: carlosho@hku.hk-
dc.identifier.emailLau, TKK: kristytk@hku.hk-
dc.identifier.emailChung, HS: mattcsh@hku.hk-
dc.identifier.emailLau, EHY: ehylau@hku.hk-
dc.identifier.emailCowling, BJ: bcowling@hku.hk-
dc.identifier.authorityWong, CKH=rp01931-
dc.identifier.authorityLau, EHY=rp01349-
dc.identifier.authorityCowling, BJ=rp01326-
dc.identifier.hkuros333330-

Export via OAI-PMH Interface in XML Formats

OR

Export to Other Non-XML Formats